Did´n rogaine hit the market under the phase III? Before it was done?
Aderans Research update
Collapse
X
-
exactly. All of their money comes from investors who can pull their money out at any time.
If the investors had no hope for their treatment to work, they would have stopped giving them money and the company would have failed.
The company is still alive. Investors believe in them, why don't you?
'Belief', in the world of investments, can be a funny term. The only company who have showed any real progress thus far is Histogen, they've fought a court battle for their procedure and won, clearly they've got something worth fighting for. The board at Replicel also looks very impressive.Comment
-
You don't get it, do you? Please inform yourself about the stages of clinical trials and what they are there for. Phase II is mostly about optimizing, optimizing and optimizing, especially for a new treatment like this.
Looking forward when people start to blame Replicel, because they need longer than expected, which is, just for the record, totally normal.Comment
-
I'll add to what krewel said in his response to you. Aderans apparently extended phase 2 to see if the hairs that were regrown went through the proper growth cycle, and if thats true, its a damn good thing that they chose to do that considering that they are trying to create a permanent solution. If they were struggling to find investors (which they aren't considering that huge recent investment they received), then I would be worried that they were having problems with growth.
These treatments aren't over-the-counter products. They go through clinical trials, and trials take time. Thats the reality, as frustrating as it can be.Comment
-
The reason Aderans Phase IIs took so long is because they had to run multiple trials because the initial results weren't so good.
The initial trials only had something like 30% of subjects achieving results of at least 13 hairs per square centimetre. Later trials had this up over 70% and presumably the best results were decently better than 13 hairs.
They are using Phase II to perfect the process because Phase III is much bigger and more expensive. Assuming they get a result they're happy to market, they should only need one Phase III.
So the argument that because Phase II took so long, Phase III is going to as well is not necessarily right. If they finish up Phase II next year and go straight into Phase III and get the results they are hoping for, we could still see Aderans on the market in 2015. But at this stage it doesn't look like a full cure. Just streets ahead of anything we have available today...Comment
-
Comment
-
@gnomasco
They started phase 1 trials in 2006. Phase 2 started in 2008.
Comment
-
Yes, phase 2 hasn't been going on since 06, but since it wouldn't be out of the realm of possibility to include phase 1 participants in phase 2, following those participants development would have an effect on how they go about with the second trial.Comment
-
Of course we don't have the kind of information that the conductors of the trials have. But its not exactly a good thing to just immediately jump to a conclusion with complete certainty when for example a trial phase is extended and say "well screw this this" or something along those lines. This board went into almost sheer hysterics when Histogen changed their website and for a period of time didn't have their trial timeline on of their pages.Comment
-
It was not this board, it was RichardDawkins, I will never forget that. I don't know what was wrong with him. Anway, we need to be patient. I'm sure nothing is wrong with Aderans...Comment
-
The reason Aderans Phase IIs took so long is because they had to run multiple trials because the initial results weren't so good.
The initial trials only had something like 30% of subjects achieving results of at least 13 hairs per square centimetre. Later trials had this up over 70% and presumably the best results were decently better than 13 hairs.
They are using Phase II to perfect the process because Phase III is much bigger and more expensive. Assuming they get a result they're happy to market, they should only need one Phase III.
So the argument that because Phase II took so long, Phase III is going to as well is not necessarily right. If they finish up Phase II next year and go straight into Phase III and get the results they are hoping for, we could still see Aderans on the market in 2015. But at this stage it doesn't look like a full cure. Just streets ahead of anything we have available today...
What happened to Acell?Comment
-
Well thats the other theory - that they've already tested "the chosen one" by the time they hit Phase III next year, so therefore Phase III shouldn't take too long. Id love to believe it however im not seeing enough media coverage, interest and general hype about a company that seems to be on the brink of one of the most greatest clinical discoveries mankind has ever seen.
What happened to Acell?
As for Acell (something that had lots of hype surrounding it), that should probably serve as evidence against the notion that "this doesn't have a lot of hype surrounding it, therefore, I shouldn't take it that seriously".Comment
-
Of course we don't have the kind of information that the conductors of the trials have. But its not exactly a good thing to just immediately jump to a conclusion with complete certainty when for example a trial phase is extended and say "well screw this this" or something along those lines. This board went into almost sheer hysterics when Histogen changed their website and for a period of time didn't have their trial timeline on of their pages.Comment
-
Those weren't my intentions. Im not trying to be Richard Dawkins. That comment was out of frustration. Even though I know Aderans is still moving along, I can't really say it's all good that they keep extending the finish line. If they had what they wanted, there would be no reason to do this. Like I said, I still believe they can get this done. But who knows when?
And you're also right about when they can get it done. None of us know when (or if) it will happen, but I support it just as much as I support Replicel, Histogen and any of the new potential treatments out there that are being worked on.Comment
Comment